 |
市場調查報告書
商品編碼
1567234
脫髮和脫髮處方藥市場：按藥物類型、性別、應用、給藥途徑、地區Prescription Hair Loss and Hair Removal Drugs Market, By Drug Type, By Gender, By Application, By Route of Administration, By Geography |
||||||
預計2024年全球脫髮和脫髮處方藥市場規模為301億美元，預計2031年將達到481.1億美元，2024年至2031年複合年成長率為6.9%。
| 報告範圍 | 報告詳情 | ||
|---|---|---|---|
| 基準年 | 2023年 | 2024年市場規模 | 301億美元 |
| 實際資料 | 2019-2023 | 預測期 | 2024年至2031年 |
| 預測 2024-2031 年複合年成長率： | 6.90% | 2031年價值預測 | 481.1億美元 |
全球脫髮和脫髮處方藥市場的成長主要是由容易出現脫髮問題的老年人口不斷增加所推動的。此外，學名藥的容易取得以及消費者對各種脫髮治療方案的認知不斷提高也推動了市場的成長。然而，與長期使用這些藥物相關的副作用以及替代治療方法的可用性可能會給行業參與者帶來挑戰。
市場動態：
全球脫髮和脫髮處方藥市場的成長是由脫髮症、雄性脫髮症和其他導致脫髮的疾病患病率上升等因素推動的。此外，越來越多的老年人面臨頭髮稀疏和禿頭的高風險，也將成為市場成長的驅動力。活性化研發活動，推出解決特定性別掉髮問題的新產品，發揮重要作用。然而，包括植髮手術、假髮和接髮在內的替代脫髮治療方法的可用性可能會阻礙市場成長。此外，長期使用脫髮藥物帶來的性副作用、憂鬱症和心臟病等副作用可能會阻礙市場成長。亞太地區和拉丁美洲的新興市場為產品滲透提供了有利可圖的機會。
本研究的主要特點
該報告對全球脫髮和脫髮處方藥市場進行了深入分析，包括以2023年為基礎的預測期（2024-2031）的市場規模（十億美元）和年複合成長率（CAGR%）年發布。
它還揭示了各個細分市場的潛在商機，並說明了該市場有吸引力的投資提案矩陣。
它還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景、主要企業採取的競爭策略等的重要見解。
根據公司亮點、產品系列、主要亮點、業績和策略等參數對全球脫髮和脫髮處方藥市場的主要企業進行了分析。
主要企業包括默克、強生、寶潔、歐萊雅、聯合利華、大正製藥、樂敦製藥、資生堂、Lifes2Good 等。
該報告的見解使負責人和公司經營團隊能夠就未來的產品發布、類型升級、市場擴張和行銷策略做出明智的決策。
全球處方除毛和除毛產品市場報告迎合了該行業的各種相關人員，如投資者、供應商、產品製造商、經銷商、新進業者和財務分析師。
相關人員可以透過用於分析全球脫髮和脫髮處方藥市場的各種策略矩陣來促進他們的決策。
目錄
第1章 研究目的與前提
- 研究目的
- 先決條件
- 簡稱
第2章 市場展望
- 報告說明
- 市場定義和範圍
- 執行摘要
第3章 市場動態、法規與趨勢分析
- 市場動態
- 促進因素
- 抑制因素
- 機會
- 影響分析
- 市場趨勢
- 主要進展
- 監管場景
- 收購和合作場景
- 資金籌措和投資
- PEST分析
- 波特的分析
第4章全球脫髮和脫髮處方藥市場 - 冠狀病毒 (COVID-19) 大流行的影響
- 整體影響
- 政府舉措
- COVID-19 對市場的影響
第5章全球脫髮和脫髮處方藥市場，按藥物類型，2019-2031
- 脫髮治療
- 口服避孕藥
- 除毛藥
第6章全球脫髮和脫髮處方藥市場，性別，2019-2031
- 男性
- 女士
第7章 全球脫髮和脫髮處方藥市場，按應用分類，2019-2031
- 慢性脫髮症
- 急性脫髮症
第8章全球脫髮和脫髮處方藥市場，依給藥途徑，2019-2031
- 外用
- 口服
- 注射
第9章全球脫髮和脫髮處方藥市場，按分銷管道，2019-2031
- 醫院藥房
- 零售藥房
- 網路藥房
第10章全球脫髮和脫髮處方藥市場，按地區，2019-2031
- 北美洲
- 拉丁美洲
- 歐洲
- 亞太地區
- 中東
- 非洲
第11章競爭格局
- 公司簡介
- Pfizer Inc.
- Merck &Co., Inc.
- Johnson &Johnson
- Bausch Health Companies Inc.
- L'Oreal SA
- Galderma SA
- Revivogen
- Hims, Inc.
- Evolus, Inc.
- Aclaris Therapeutics, Inc.
- Amgen Inc.
- Sientra, Inc.
- Dr. Reddy's Laboratories Ltd.
- Boehringer Ingelheim
- Bristol-Myers Squibb
- Sun Pharmaceutical Industries Ltd.
- Cipla Limited
- Mylan NV
- Zynerba Pharmaceuticals, Inc.
- Apex Therapeutics, LLC
第12章分析師建議
第13章 參考文獻與調查方法
- 參考
- 調查方法
Global prescription hair loss and hair removal drugs market is estimated to be valued at USD 30.10 Bn in 2024 and is expected to reach USD 48.11 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 6.9% from 2024 to 2031.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2023 | Market Size in 2024: | US$ 30.10 Bn |
| Historical Data for: | 2019 to 2023 | Forecast Period: | 2024 to 2031 |
| Forecast Period 2024 to 2031 CAGR: | 6.90% | 2031 Value Projection: | US$ 48.11 Bn |
Prescription hair loss refers to the loss of hair from the scalp or other parts of the body that occurs due to aging, hormonal changes, medical conditions, stress or genetic predisposition. Global prescription hair loss and hair removal drugs market growth is driven primarily by rising geriatric population who are more prone to hair fall issues. Furthermore, easy availability of generic drugs coupled with growing consumer awareness about various treatment options for hair loss can also drive the market growth. However, side effects associated with prolonged usage of these drugs and availability of alternative treatments can pose challenges to industry players.
Market Dynamics:
Global prescription hair loss and hair removal drugs market growth is driven by factors like rising prevalence of alopecia areata, androgenic alopecia and other medical conditions causing hair loss. Growing geriatric population who are at an increased risk of suffering from hair thinning and balding can also drive the market growth. Rising R&D activities leading to new product launches catering to gender-specific hair loss issues plays a crucial role. However, factors such as availability of alternative hair loss treatments including hair transplant surgery, wigs and hair extensions can hamper the market growth. Moreover, side effects associated with long term use of hair loss drugs such as sexual side effects, depression and heart issues can hamper the market growth. Emerging markets in Asia Pacific and Latin America present lucrative opportunities for product penetration.
Key features of the study:
This report provides in-depth analysis of the global prescription hair loss and hair removal drugs market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global prescription hair loss and hair removal drugs market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Merck, Johnson & Johnson, Procter & Gamble, L'Oreal, Unilever, Taisho Pharmaceuticals, Rohto Pharmaceutical, Shiseido, and Lifes2Good
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
Global prescription hair loss and hair removal drugs market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global prescription hair loss and hair removal drugs market
Detailed Segmentation-
- By Drug Type Insights (Revenue, USD Bn, 2019 - 2031)
- Hair Loss Medications
- Oral Contraceptive Pills
- Hair Removal Medications
- By Gender Insights (Revenue, USD Bn, 2019 - 2031)
- Male
- Female
- By Application Insights (Revenue, USD Bn, 2019 - 2031)
- Chronic Hair Loss
- Acute Hair Loss
- By Route of Administration Insights (Revenue, USD Bn, 2019 - 2031)
- Topical
- Oral
- Injectable
- By Distribution Channel Insights (Revenue, USD Bn, 2019 - 2031)
- Hospital pharmacies
- Retail pharmacies
- Online pharmacies
- By Regional Insights (Revenue, USD Bn 2019 - 2031)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- Pfizer Inc.
- Merck & Co., Inc.
- Johnson & Johnson
- Bausch Health Companies Inc.
- L'Oreal S.A.
- Galderma S.A.
- Revivogen
- Hims, Inc.
- Evolus, Inc.
- Aclaris Therapeutics, Inc.
- Amgen Inc.
- Sientra, Inc.
- Reddy's Laboratories Ltd.
- Boehringer Ingelheim
- Bristol-Myers Squibb
- Sun Pharmaceutical Industries Ltd.
- Cipla Limited
- Mylan N.V.
- Zynerba Pharmaceuticals, Inc.
- Apex Therapeutics, LLC
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Drug Type
- Market Snapshot, By Gender
- Market Snapshot, By Application
- Market Snapshot, By Route of Administration
- Market Snapshot, By Distribution Channel
- Market Snapshot, By Region
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Opportunities
- Impact Analysis
- Market Trends
- Key Developments
- Regulatory Scenario
- Acquisitions and Partnerships Scenario
- Funding and Investments
- PEST Analysis
- Porter's Analysis
4. Global Prescription Hair Loss and Hair Removal Drugs Market - Impact of Coronavirus (COVID-19) Pandemic
- Overall Impact
- Government Initiatives
- COVID-19 Impact on the Market
5. Global Prescription Hair Loss and Hair Removal Drugs Market, By Drug Type, 2019 - 2031, (USD Bn)
- Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
- Hair Loss Medications
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Oral Contraceptive Pills
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Hair Removal Medications
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
6. Global Prescription Hair Loss and Hair Removal Drugs Market, By Gender, 2019 - 2031, (USD Bn)
- Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
- Male
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Female
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
7. Global Prescription Hair Loss and Hair Removal Drugs Market, By Application, 2019 - 2031, (USD Bn)
- Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
- Chronic Hair Loss
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Acute Hair Loss
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
8. Global Prescription Hair Loss and Hair Removal Drugs Market, By Route of Administration, 2019 - 2031, (USD Bn)
- Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
- Topical
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Oral
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Injectable
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
9. Global Prescription Hair Loss and Hair Removal Drugs Market, By Distribution Channel, 2019 - 2031, (USD Bn)
- Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
- Hospital Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Retail Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Online Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
10. Global Prescription Hair Loss and Hair Removal Drugs Market, By Region, 2019 - 2031, (USD Bn)
- Introduction
- Market Share Analysis, By Region, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, For Region, 2020-2031
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Gender, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Gender, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Gender, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Gender, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Gender, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Gender, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2019 - 2031, (USD Bn)
- North Africa
- Central Africa
- South Africa
11. Competitive Landscape
- Company Profiles
- Pfizer Inc.
- Company Highlights
- Gender Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Merck & Co., Inc.
- Johnson & Johnson
- Bausch Health Companies Inc.
- L'Oreal S.A.
- Galderma S.A.
- Revivogen
- Hims, Inc.
- Evolus, Inc.
- Aclaris Therapeutics, Inc.
- Amgen Inc.
- Sientra, Inc.
- Dr. Reddy's Laboratories Ltd.
- Boehringer Ingelheim
- Bristol-Myers Squibb
- Sun Pharmaceutical Industries Ltd.
- Cipla Limited
- Mylan N.V.
- Zynerba Pharmaceuticals, Inc.
- Apex Therapeutics, LLC
- Pfizer Inc.
12. Analyst Recommendation
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
13. References and Research Methodology
- References
- Research Methodology
- About Us and Sales Contact
脫髮治療產品市場－全球產業規模、佔有率、趨勢、機會和預測（按產品類型、按最終用戶、按配銷通路、按地區和競爭情況，2020-2030 年）
脫髮治療產品市場：按產品、性別、分銷管道和最終用戶 - 2025-2030 年全球預測
脫髮治療產品市場：依產品類型、通路和地區，2024年至2031年
雷射除毛治療市場：按雷射類型、最終用途分類 - 2025-2030 年全球預測
雷射除毛治療的全球市場（2024-2028）
全球脫髮治療產品市場，2024-2028
全球脫髮治療產品的市場評估：依產品類型、依成分、依應用、依價格、依類別、依最終用戶、依分銷渠道、依地區、機會、預測（2017-2031）
脫髮治療市場：按產品類型、按給藥途徑、按性別、按配銷通路、按地區
脫髮治療的全球市場 (2019-2029年):各類型、性、終端用戶、地區的市場規模、佔有率、趨勢分析、機會、預測